Bioactive constituents from chinese natural medicines. XI. Inhibitors on NO production and degranulation in RBL-2H3 from Rubia yunnanensis: Structures of rubianosides II, III, and IV, rubianol-g, and rubianthraquinone

Chemical and Pharmaceutical Bulletin

Volumn 51, Issue 6, 2003, Pages 654-662

  Tao, Jing ^a   Morikawa, Toshio ^a   Ando, Shin ^a   Matsuda, Hisashi ^a   Yoshikawa, Masayuki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cyclic peptide; Degranulation inhibitor; Nitric oxide inhibitor; Rubia yunnanensis; Rubianoside; Rubianthraquinone

Indexed keywords

2 METHYL 1,3,6 TRIHYDROXY 9,10 ANTHRAQUINONE; 5 METHOXYLARICIRESINOL; ANTHRAQUINONE DERIVATIVE; DEOXYBOUVADIN; ISOLARICIRESINOL; LARICIRESINOL; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; RUBIANOL A; RUBIANOL B; RUBIANOL C; RUBIANOL D; RUBIANOL E; RUBIANOL G; RUBIANOSIDE 12; RUBIANOSIDE 2; RUBIANOSIDE 3; RUBIANOSIDE 4; RUBIANTHRAQUINONE; RUBIARBONOL A; RUBIARBONOL F; RUBIARBONOL I; RUBIARBONONE B; RUBIARBONONE C; RUBINAPHTHIN A; SECOISOLARICIRESINOL; SYRINGIC ACID; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ARTICLE; CHINESE MEDICINE; DEGRANULATION; DRUG ACTIVITY; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME RELEASE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PLANT ROOT; RAT; RUBIA; RUBIA YUNNANENSIS;

EID: 0042500410     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.51.654     Document Type: Article

References (45)

1. Part X: Morikawa T., Tao J., Ando S., Matsuda H., Yoshikawa M., J. Nat. Prod., 66 (2003), in press.
2. Matsuda H., Kageura T., Inoue Y., Morikawa T., Yoshikawa M., Tetrahedron, 56, 7763-7777 (2000).
3. Yoshikawa M., Murakami T., Ueno T., Yashiro K., Hirokawa N., Murakami N., Yamahara J., Matsuda H., Saijoh R., Tanaka O., Chem. Pharm. Bull., 45, 1039-1045 (1997).
4. Yoshikawa M., Murakami T., Ueno T., Hirokawa N., Yashiro K., Murakami N., Yamahara J., Matsuda H., Saijoh R., Tanaka O., Chem. Pharm. Bull., 45, 1056-1062 (1997).
5. Yoshikawa M., Morikawa T., Yashiro K., Murakami T., Matsuda H., Chem. Pharm. Bull., 49, 1452-1456 (2001).
6. Matsuda H., Pongpiriyadacha Y., Morikawa T., Kishi A., Kataoka S., Yoshikawa M., Bioorg. Med. Chem. Lett., 13, 1101-1106 (2003).
7. Zou C., Hao X.-J., Chen C.-X., Zhou J., Acta Bot. Yunnan., 14, 114 (1992).
8. 1,15)
9. Duh C.-Y., Phoebe C. H., Jr., Pezzuto J. M., Kinghorn A. D., Farnsworth N. R., J. Nat. Prod., 49, 706-709 (1986).
10. Chen Y.-Q., Luo Y.-R., Youji Huaxue, 11, 523-524 (1991).
11. Liou M.-J., Wu P.-L., Wu T.-S., Chem. Pharm. Bull., 50, 276-279 (2002).
12. Morita H., Yamamiya T., Takeya K., Itokawa H., Chem. Pharm. Bull., 40, 1352-1354 (1992).
13. Morita H., Yamamiya T., Takeya K., Itokawa H., Sakuma C., Yamada J., Suga T., Chem. Pharm. Bull., 41, 781-783 (1993).
14. 1H COSY), and HMBC experiments.
15. Yokosuka A., Mimaki Y., Sashida Y., J. Nat. Prod., 63, 1239-1243 (2000).
16. Ohtani I., Kusumi T., Kashman Y., Kakisawa H., J. Am. Chem. Soc., 113, 4092-4096 (1991).
17. 18) at the same time as our study was done. However, the absolute stereostructures of 3 and 4 were not characterized. Morikawa T., Tao J., Matsuda H., Yoshikawa M., Abstract of Papers, the 49th Annual Meeting of the Japanese Society of Pharmacognosy, Fukuoka, September 2002, p. 138.
18. Liou M.-J., Wu T.-S., J. Nat. Prod., 65, 1283-1287 (2002).
19. Itokawa H., Qiao Y.-F., Takeya K., Chem. Pharm. Bull., 38, 1435-1437 (1990).
20. Yoshikawa M., Murakami T., Shimada H., Yoshizumi S., Saka M., Yamahara J., Matsuda H., Chem. Pharm. Bull., 46, 1008-1014 (1998).
21. Matsuda H., Murakami T., Kageura T., Ninomiya K., Toguchida I., Nishida N., Yoshikawa M., Bioorg. Med. Chem. Lett., 8, 2191-2196 (1998).
22. Yoshikawa M., Morikawa T., Toguchida I., Harima S., Matsuda H., Chem. Pharm. Bull., 48, 651-656 (2000).
23. Matsuda H., Kageura T., Morikawa T., Toguchida I., Harima S., Yoshikawa M., Bioorg. Med. Chem. Lett., 10, 323-327 (2000).
24. Kageura T., Matsuda H., Morikawa T., Toguchida I., Harima S., Oda M., Yoshikawa M., Bioorg. Med. Chem., 9, 1887-1893 (2001).
25. Matsuda H., Kageura T., Oda M., Morikawa T., Sakamoto Y., Yoshikawa M., Chem. Pharm. Bull., 49, 716-720 (2001).
26. Matsuda H., Ninomiya K., Morikawa T., Yoshikawa M., Bioorg. Med. Chem. Lett., 8, 339-344 (1998).
27. Matsuda H., Morikawa T., Toguchida I., Ninomiya K., Yoshikawa M., Heterocycles, 55, 841-846 (2001).
28. Matsuda H., Morikawa T., Toguchida I., Ninomiya K., Yoshikawa M., Chem. Pharm. Bull., 49, 1558-1566 (2001).
29. Matsuda H., Kageura T., Toguchida I., Ueda H., Morikawa T., Yoshikawa M., Life Sci., 66, 2151-5157 (2000).
30. Muraoka O., Fujimoto M., Tanabe G., Kubo M., Minematsu T., Matsuda H., Morikawa T., Toguchida I., Yoshikawa M., Bioorg. Med. Chem. Lett., 11, 2217-2220 (2001).
31. Morikawa T., Matsuda H., Toguchida I., Ueda K., Yoshikawa M., J. Nat. Prod., 65, 1468-1474 (2002).
32. Matsuda H., Morikawa T., Sakamoto Y., Toguchida I., Yoshikawa M., Heterocycles, 56, 45-50 (2002).
33. Matsuda H., Morikawa T., Sakamoto Y., Toguchida I., Yoshikawa M., Bioorg. Med. Chem., 10, 2527-2534 (2002).
34. Matsuda H., Kageura T., Toguchida I., Murakami T., Kishi A., Yoshikawa M., Bioorg. Med. Chem. Lett., 9, 3081-3086 (1999).
35. Tao J., Morikawa T., Toguchida I., Ando S., Matsuda H., Yoshikawa M., Bioorg. Med. Chem., 10, 4005-4012 (2002).
36. Morikawa T., Tao J., Toguchida I., Matsuda H., Yoshikawa M., J. Nat. Prod., 66, 86-91 (2003).
37. Itokawa H., Takeya K., Mihara K., Mori N., Hamanaka T., Sonobe T., Iitaka Y., Chem. Pharm. Bull., 31, 1424-1427 (1983).
38. Itokawa H., Takeya K., Mori N., Sonobe T., Serisawa N., Hamanaka T., Mihashi S., Chem. Pharm. Bull., 32, 3216-3226 (1984).
39. Schwartz L. B., Lewis R. A., Seldin D., Austen K. F., J. Immunol., 126, 1290-1294 (1981).
40. Marquardt D. L., Wasserman S. I., J. Immunol., 131, 934-939 (1983).
41. Matsuda H., Morikawa T., Tao J., Ueda K., Yoshikawa M., Chem. Pharm. Bull., 50, 208-215 (2002).
42. Morikawa T., Tao J., Ueda K., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 51, 62-67 (2003).
43. Morikawa T., Matsuda H., Sakamoto Y., Ueda K., Yoshikawa M., Chem. Pharm. Bull., 50, 1045-1049 (2002).
44. Matsuda H., Morikawa T., Ueda K., Managi H., Yoshikawa M., Bioorg. Med. Chem., 10, 3123-3128 (2002).
45. 42) As a result, 23 did not affect the enzyme activity of β-hexosaminidase (8.0±1.1% inhibition at 100 μM).